About GeneNews (TSE:GEN)
GeneNews Limited is focused on developing and commercializing molecular diagnostic tests for early detection of diseases and for personalized health management, with a primary focus on cancer-related indications. The Company offers Sentinel Principle, which is a platform technology to detect virtually any disease or medical condition from a simple blood sample. The Company also offers ColonSentry, which is a blood-based test for assessing an individual's current risk of having colorectal cancer. The Company operates within the biotechnology, molecular diagnostic and genomic biomarker industry. The Company operates in Canada and the United States, and transacts business primarily with the United States partners and suppliers. The Company's subsidiaries include GeneNews Corporation and GeneNews Inc.
Industry, Sector and Symbol
Industry Medical Laboratories & Research
Trailing P/E Ratio-5
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on Assets-81.53%
GeneNews (TSE:GEN) Frequently Asked Questions
What is GeneNews' stock symbol?
GeneNews trades on the Toronto Stock Exchange (TSX) under the ticker symbol "GEN."
How were GeneNews' earnings last quarter?
GeneNews Ltd (TSE:GEN) issued its earnings results on Tuesday, November, 14th. The company reported ($0.01) earnings per share for the quarter. View GeneNews' Earnings History.
When will GeneNews make its next earnings announcement?
Who are some of GeneNews' key competitors?
Some companies that are related to GeneNews include IntelliPharmaCeutics Intl (IPCI), Uroplasty (UPI), Eleven Biotherapeutics (EBIO), Prana Biotechnology (PRAN), ContraVir Pharmaceuticals (CTRV), Repros Therapeutics (RPRX), WaferGen Bio-systems (WGBS), Bio-Path (BPTH), Invivo Therapeutics (NVIV), Sonoma Pharmaceuticals (SNOA), Auris Medical (EARS), Biocept (BIOC), Eyegate Pharmaceuticals (EYEG), Zosano Pharma (ZSAN), Onconova Therapeutics (ONTX), Cellectar Biosciences (CLRB), Soleno Therapeutics (SLNO) and Anthera Pharmaceuticals (ANTH).
Who are GeneNews' key executives?
GeneNews' management team includes the folowing people:
- James R. Howard-Tripp, Chairman of the Board, Chief Executive Officer
- Leslie Auld, Chief Financial Officer, Treasurer, Director
- Heinrich Dreismann Ph.D., Lead Director (Age 64)
- Harry A. Glorikian, Independent Director (Age 50)
- Rory B. Riggs, Independent Director (Age 64)
How do I buy GeneNews stock?
Shares of GeneNews and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is GeneNews' stock price today?
One share of GeneNews stock can currently be purchased for approximately C$0.15.
How big of a company is GeneNews?
GeneNews has a market capitalization of C$14.44 million.
How can I contact GeneNews?
GeneNews' mailing address is 445 Apple Creek Blvd Unit 220, MARKHAM, ON L3R 9X7, Canada. The company can be reached via phone at +1-905-7392030.
MarketBeat Community Rating for GeneNews (GEN)MarketBeat's community ratings are surveys of what our community members think about GeneNews and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
GeneNews (TSE:GEN) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
GeneNews (TSE:GEN) Earnings History and Estimates Chart
GeneNews (TSE GEN) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/2/2018|| || || || || || || || |
|5/15/2014||C($0.04)||C($0.02)||C$0.04 million||C$0.20 million||View||N/A|
GeneNews (TSE:GEN) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for GeneNews (TSE:GEN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for GeneNews (TSE GEN)
No insider trades for this company have been tracked by MarketBeat.com
GeneNews (TSE GEN) News Headlines
GeneNews (TSE:GEN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
GeneNews (TSE GEN) Stock Chart for Tuesday, January, 16, 2018